UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients

Sponsor

University of Arkansas (Other)

Overall Status

Withdrawn

CT.gov ID

NCT01622595

Collaborator

(none)

Enrollment

Location

Duration (Months)

Patients Per Site Per Month

Study Details

OBSERVATIONAL STUDY OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS

Condition or Disease	Intervention/Treatment	Phase
Aspergillosis Candidemia C. Difficile

A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS

Study Type:

Observational

Actual Enrollment :

0 participants

Observational Model:

Case-Only

Time Perspective:

Retrospective

Official Title:

A Non-interventional Observational Study of Infectious Complications in Cancer Patients

Study Start Date :

Nov 1, 2009

Anticipated Primary Completion Date :

Dec 1, 2015

Anticipated Study Completion Date :

Dec 1, 2015

To study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients [3 years]
To study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients

incidence [3 years]
To determine the overall incidence of different infections, including bacterial, fungal and viral infections in cancer patients receiving chemotherapy and / or hematopoietic stem cell transplantation. To describe the natural history of such infections in cancer patients. To monitor the adherence of Myeloma institute for research and therapy(MIRT) health care workers to the MIRT standard operational procedures (SOPs) To identify risk factors for the development of specific infections. To validate surrogate markers as early diagnostic tools for various infections.